Cargando…
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis
Metformin has garnered considerable interest as a chemo-preventive and chemo-therapeutic agent given the increased risk of liver cancer among diabetic patients. This work was performed to illustrate the association between metformin use and survival of diabetic liver cancer patients. We conducted a...
Autores principales: | Ma, Shu-Juan, Zheng, Yi-Xiang, Zhou, Peng-Cheng, Xiao, Yan-Ni, Tan, Hong-Zhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323227/ https://www.ncbi.nlm.nih.gov/pubmed/27494848 http://dx.doi.org/10.18632/oncotarget.11033 |
Ejemplares similares
-
Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
por: Ma, Shujuan, et al.
Publicado: (2017) -
Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017) -
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017) -
Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
por: Shi, Yu-Qi, et al.
Publicado: (2020) -
The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017)